重庆港：国投交通未减持公司股份，减持计划时间区间届满

Group 1 - Chongqing Port announced on October 24 that as of the end of the current share reduction plan, Guotou Transportation did not reduce its shareholding in the company [1] Group 2 - In 2023, China's innovative drugs have generated $80 billion in overseas licensing deals [1] - The secondary market for biopharmaceuticals is experiencing a surge, while the primary market is facing challenges in fundraising [1]